Pulse Biosciences
PLSE
47 hedge funds and large institutions have $20.5M invested in Pulse Biosciences in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 10 closing their positions.
155% more call options, than puts
Call options by funds: $680K | Put options by funds: $267K
8% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 13
2.21% less ownership
Funds ownership: 11.2% → 8.99% (-2.2%)
6% less funds holding
Funds holding: 50 → 47 (-3)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
53% less capital invested
Capital invested by funds: $43.2M → $20.5M (-$22.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$546K |
| 2 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$290K |
| 3 |
VF
Virtu Financial
New York
|
+$220K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$197K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$128K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$5.81M |
| 2 |
TAM
Tocqueville Asset Management
New York
|
-$507K |
| 3 |
Millennium Management
New York
|
-$290K |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$248K |
| 5 |
FC
Fore Capital
New York
|
-$236K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Squarepoint
New York
| – | -$229K | -9,690 | Closed |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| – | -$190K | -8,030 | Closed |
|
|
SO
53
STRS Ohio
Columbus,
Ohio
| – | -$63K | -2,700 | Closed |
|
54
Parallax Volatility Advisers
San Francisco,
California
| – | -$34K | -1,428 | Closed |
|
55
Simplex Trading
Chicago,
Illinois
| – | -$9.46K | -498 | Closed |
|
PLSE Hedge Fund Activity: Q1 2018 in Review
47 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2018, worth a combined $20.5M — down 53% from $43.2M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of PLSE and 7 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 12 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $546K. The largest seller was Citadel Advisors, cutting an estimated $5.81M.
- 47 institutional investors held Pulse Biosciences (PLSE) as of Q1 2018, down from 50 in Q4 2017.
- Funds reported $20.5M of Pulse Biosciences stock for Q1 2018, down 53% quarter-over-quarter.
- 7 funds opened new Pulse Biosciences positions in Q1 2018 and 10 closed out, a net change of -3 holders.
- The largest Pulse Biosciences buyer in Q1 2018 was Susquehanna International Group, an estimated $546K added.
- The largest Pulse Biosciences seller in Q1 2018 was Citadel Advisors, an estimated $5.81M sold.
Based on aggregated 13F filings for Q1 2018.